TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
MARKET INSIGHTS
Global Scissors Type Ultrasonic Scalpel market size was valued at USD 323 million in 2025. The market is projected to grow from USD 323 million in 2025 to USD 476 million by 2032, exhibiting a CAGR of 5.8% during the forecast period.
Scissors Type Ultrasonic Scalpel is a special ultrasonic surgical scalpel that converts electrical energy into mechanical energy and transmits ultrasound to the cutter, causing it to vibrate and separate and cut fibrous tissue. It usually consists of a main unit, a therapeutic sound head (i.e., a knife head), and a special wire connecting the two. High‑frequency sound wave vibrations enable precise tissue cutting, delivering high surgical precision, reduced trauma, and minimal bleeding. The device is widely employed in neurosurgery, cardiac surgery, breast surgery and other clinical fields.
The global Scissors Type Ultrasonic Scalpel market was valued at 323 million in 2025 and is projected to reach US$ 476 million by 2032, at a CAGR of 5.8% during the forecast period.
Scissors Type Ultrasonic Scalpel is a special ultrasonic surgical scalpel that converts electrical energy into mechanical energy and transmits ultrasound to the cutter, causing it to vibrate and separate and cut fibrous tissue. Scissors type ultrasonic scalpel usually consists of a main unit, a therapeutic sound head (i.e., a knife head), and a special wire connecting the two. It uses high-frequency sound wave vibrations to cut tissue. It has the advantages of high surgical precision, less trauma, and less bleeding. It is widely used in neurosurgery, cardiac surgery, breast surgery and other fields.
The U.S. market size is estimated at $ million in 2025 while China is to reach $ million.
9 cm segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Scissors Type Ultrasonic Scalpel include Johnson & Johnson, Surgnova, Hemony Pharmaceutical, ShanghaiSAINTS SAGESSurgical, Innolcon Medical Technology, Beijing Taktvoll Technology, Stryker, etc. In 2025, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Scissors Type Ultrasonic Scalpel manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
This report aims to provide a comprehensive presentation of the global market for Scissors Type Ultrasonic Scalpel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scissors Type Ultrasonic Scalpel. This report contains market size and forecasts of Scissors Type Ultrasonic Scalpel in global, including the following market information:
Increased Use of Next-generation Sequencing to Drive Use of DNA Modifying Enzymes
Next-Generation Sequencing (NGS) is revolutionizing genomics research by enabling the sequencing of millions of DNA fragments simultaneously. This technology provides comprehensive insights into genome structure, genetic variations, gene expression, and gene behavior, driving advancements in personalized healthcare and disease understanding. Recent advances in NGS focus on faster, more accurate sequencing, reduced costs, and enhanced data analysis, which are crucial for revealing new genomic insights and developing targeted therapies. Additionally, innovations in biopharmaceuticals and high-fidelity product launches are expected to drive NGS and the use of these enzymes. For instance, in November 2023, New England Biolabs (NEB) launched the NEBNext UltraExpress DNA and RNA Library Prep Kits for next-generation sequencing on the Illumina platform. Such advancements are expected to fuel the market growth.
Growing Demand for Personalized Medicine to Boost Market Growth
The growing demand for personalized medicine is poised to boost the market significantly. Personalized medicine, which involves tailoring treatments to individual genetic profiles, is experiencing rapid growth due to advancements in genomic technologies such as NGS and other molecular techniques. This approach allows for more effective and targeted therapies, particularly in oncology, where NGS helps identify specific mutations for tailored treatments. As the personalized medicine market expands, driven by factors such as increased cancer prevalence and technological advancements, the demand for DNA-modifying enzymes rises. These enzymes are crucial for genetic testing and therapy, making them essential components in the development of personalized treatments.
Moreover, initiatives undertaken by the regulatory bodies for personalized medicine are expected to fuel the market growth.
➤ For instance, the U.S. Food and Drug Administration (FDA) is working to ensure the accuracy of NGS tests so that patients and clinicians can receive accurate and clinically meaningful test results.
Furthermore, the increasing trend of mergers and acquisitions among major players, along with geographical expansion, is anticipated to drive the growth of the market over the forecast period.
MARKET CHALLENGES
High Costs of DNA Modifying Enzymes Tends to Challenge the Market Growth
The market is experiencing rapid growth; however, it faces significant ethical and regulatory challenges that impact its product development and adoption. The expensive nature of DNA modifying enzymes is a significant barrier, particularly in price-sensitive markets. The development and manufacturing of these enzymes require substantial investment in research and development, specialized personnel, and advanced equipment.
Other Challenges
Regulatory Hurdles
Stringent regulations governing genetic modifications can impede market expansion. Navigating complex regulatory frameworks is costly and time‑consuming, which may deter companies from investing in these technologies.
Ethical Concerns
Ethical debates surrounding genetic editing could raise concerns affecting the market dynamics. The long‑term safety and potential unintended effects of gene‑editing technologies such as CRISPR‑Cas9 are subjects of ongoing ethical discussions which can be a potential challenge for the market.
Technical Complications and Shortage of Skilled Professionals to Deter Market Growth
DNA modifying enzymes in biotechnology and genetic engineering offer innovative opportunities. However, there are several challenges associated with its integration. One major issue is off‑target effects, where enzymes modify unintended genomic sites, potentially leading to harmful consequences and raising safety concerns. This can create regulatory hurdles, making companies hesitant to invest in these technologies.
Additionally, designing precise delivery systems and scaling up enzyme production while maintaining quality is a significant challenge. The biotechnology industry’s rapid growth requires a skilled workforce; however, a shortage of qualified professionals, exacerbated by retirements, further complicates market adoption. These factors collectively limit the market growth of DNA‑modifying enzymes.
Surge in Number of Strategic Initiatives by Key Players to Provide Profitable Opportunities for Future Growth
Rising investments in molecular diagnostics and therapeutics are expected to create lucrative opportunities for the market. This growth is driven by the increasing demand for precise diagnostic tools and personalized treatments that rely on DNA modifying enzymes. Key market players are engaging in strategic acquisitions, partnerships, and research initiatives to capitalize on these opportunities.
Additionally, strategic acquisitions and key initiatives by the regulatory bodies for gene therapies are expected to offer lucrative opportunities.
The global Scissors Type Ultrasonic Scalpel market was valued at US$ 323 million in 2025 and is projected to reach US$ 476 million by 2032, growing at a CAGR of 5.8 %.
9 cm Scissors Segment Leads the Market Due to Its Superior Precision in Neurosurgical Procedures
The market is segmented based on product type into:
9 cm scissors
Features: high frequency vibration, ergonomic handle, disposable or reusable options
17 cm scissors
Features: longer reach for cardiac and thoracic applications
Disposable sound heads
Reusable sound heads
Integrated main units with advanced power modules
Accessories (wiring kits, sterilization containers)
Others
Neurosurgery Application Dominates Due to High Demand for Minimal‑Trauma Tissue Dissection
The market is segmented based on application into:
Neurosurgery
Cardiac surgery
Breast surgery
General surgery
Veterinary surgery
Others
Hospital Operating Rooms Capture the Largest Share Owing to High Procedure Volumes
The market is segmented based on end user into:
Hospitals (public and private)
Ambulatory surgical centers
Research and academic institutions
Veterinary clinics
Others
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The global Scissors Type Ultrasonic Scalpel market was valued at US$323 million in 2025 and is projected to reach US$476 million by 2032, expanding at a CAGR of 5.8 % over the forecast period. This growth is driven by the device’s ability to provide high surgical precision, reduced tissue trauma, and minimal bleeding, which makes it increasingly favored in neurosurgery, cardiac surgery, and breast surgery. While the United States remains the largest regional market, rapid adoption is also evident in China, reflecting broad geographic demand for advanced ultrasonic surgical technologies.
In this semi‑consolidated market, a handful of large multinational firms dominate, supported by a range of medium‑size innovators. Johnson & Johnson leads the segment thanks to its extensive distribution network and continuous innovation in ultrasonic energy delivery. Stryker Corporation follows closely, leveraging its strong surgical portfolio and recent launch of a 9 cm scissors‑type head that has been gaining traction in North American operating rooms.
Surgnova and Hemony Pharmaceutical have secured significant shares by focusing on specialized 17 cm heads tailored for cardiac procedures, where longer reach and higher power output are critical. ShanghaiSAINTS SAGE Surgical and Innolcon Medical Technology are expanding rapidly across Asian markets, capitalizing on regional price competitiveness and growing hospital infrastructure. Beijing Taktvoll Technology meanwhile has entered strategic partnerships with leading Chinese university hospitals, accelerating product adoption through joint clinical studies.
These companies’ growth initiatives—such as geographic expansion into emerging markets, launch of next‑generation ultrasonic heads, and collaborative R&D projects—are expected to further reshape market share distribution through 2032. Concurrently, firms like Hemony Pharmaceutical and Surgnova are investing heavily in R&D to develop smaller‑profile 9 cm scissors that promise even finer tissue dissection, addressing surgeon demand for precision in minimally invasive procedures.
Johnson & Johnson
Stryker Corporation
Surgnova
Hemony Pharmaceutical
ShanghaiSAINTS SAGE Surgical
Innolcon Medical Technology
Beijing Taktvoll Technology
Shanghai SAINTS
Medtronic PLC
The global Scissors Type Ultrasonic Scalpel market was valued at US$323 million in 2025 and is projected to reach US$476 million by 2032, expanding at a compound annual growth rate of 5.8 % over the forecast horizon. This specialized ultrasonic surgical instrument converts electrical energy into high‑frequency mechanical vibrations that enable the cutter to separate fibrous tissue with exceptional precision, minimal trauma, and reduced intra‑operative bleeding. A typical system comprises a main power unit, a therapeutic sound head (the knife), and a dedicated transmission wire, delivering consistent energy to the cutting element. Its clinical advantages have driven rapid adoption across high‑impact specialties such as neurosurgery, cardiac surgery, and breast surgery. In the United States, the market size is estimated to be several tens of millions of dollars in 2025, while China is poised to become the second‑largest regional market, reflecting expanding minimally invasive programs. The 9 cm blade segment alone is expected to achieve a multi‑million‑dollar valuation by 2032, delivering a robust CAGR that mirrors overall market momentum. Leading manufacturers—including Johnson & Johnson, Surgnova, Hemony Pharmaceutical, ShanghaiSAINTS SAGESSurgical, Innolcon Medical Technology, Beijing Taktvoll Technology, and Stryker—collectively commanded roughly 40 % of global revenue in 2025, underscoring a concentrated competitive landscape.
Personalized Minimally Invasive Surgery
Hospitals are increasingly prioritizing patient‑specific, minimally invasive procedures that demand ultra‑precise cutting tools. The Scissors Type Ultrasonic Scalpel satisfies this need by delivering consistent energy output that can be fine‑tuned to individual tissue characteristics, thereby supporting personalized surgical protocols. Recent surveys of manufacturers, distributors, and clinical experts reveal a clear shift toward integrating these scalpels into bundled service offerings, especially in high‑volume centers performing neurosurgical tumor resections and coronary artery bypass grafts. The heightened focus on reducing operative blood loss and shortening hospital stays has accelerated procurement cycles, with the top five vendors collectively capturing an estimated approximately 40 % of the market share in revenue terms, reinforcing their strategic advantage in technology innovation and service support.
Application diversification is a primary growth engine for the sector. In 2025, neurosurgery accounted for the largest share of Scissors Type Ultrasonic Scalpel usage, driven by the need for precise dissection of delicate brain tissue. Cardiac surgery followed closely, leveraging the instrument’s ability to minimize thermal spread during valve repairs and coronary bypasses. Breast surgery, particularly oncologic lumpectomies, has shown a rapid uptake due to reduced postoperative pain and improved cosmetic outcomes. Regional analysis indicates that North America remains the dominant market, with the United States contributing the bulk of revenue, while Asia‑Pacific—led by China and Japan—exhibits the fastest growth rate, fueled by expanding surgical infrastructure and government incentives for advanced medical devices. This report compiles quantitative forecasts (2021‑2026 and 2027‑2032) for revenue and unit sales, outlines the segmentation by blade length (9 cm and 17 cm), and presents a comprehensive chapter framework covering market overview, competitive landscape, segment‑wise analysis, regional dynamics, and strategic insights to aid stakeholders in making informed investment and operational decisions.
North America continues to dominate the Scissors Type Ultrasonic Scalpel market, representing roughly 38% of total revenue in 2025. The United States alone accounts for the majority of this share, driven by a mature healthcare ecosystem, extensive adoption of minimally invasive surgical techniques, and strong reimbursement frameworks that encourage the use of advanced energy‑based devices. Major academic medical centers in the Midwest and West Coast have integrated scissors‑type ultrasonic scalpels into neurosurgical, cardiac, and breast‑oncology suites, citing the instrument’s ability to provide precise tissue dissection with minimal thermal spread. Canada and Mexico, while smaller in absolute terms, contribute to regional momentum through rising private‑hospital investments and growing demand for high‑precision surgical tools. The presence of leading manufacturers such as Johnson & Johnson, Stryker, and Surgnova, each maintaining R&D facilities and supply chains within the continent, further consolidates North America’s leadership. Moreover, the region benefits from robust clinical‑trial activity that continuously validates the safety and efficacy of scissors‑type ultrasonic technology, encouraging rapid diffusion across both tertiary and community hospitals.
Key Highlights:
Asia‑Pacific is forecast to be the fastest‑growing region, with an expected compound annual growth rate of approximately 7.2% between 2026 and 2034. The surge is propelled by rapid urbanization, expanding middle‑class populations, and sizable government health‑care spending in China, India, Japan, and South Korea. National initiatives such as China’s “Healthy China 2030” plan and India’s “Ayushman Bharat” scheme are increasing surgical volumes and prompting hospitals to upgrade to advanced energy‑based instruments. The 9 cm and 17 cm scissors‑type ultrasonic scalpel segments are seeing particularly robust demand, as surgeons in high‑throughput centers prioritize devices that reduce operative time and postoperative bleeding. Additionally, a growing number of private hospital chains are expanding across secondary cities, creating new install bases for ultrasonic scalpel systems. The region also benefits from a rising pool of trained surgeons who have participated in international workshops and fellowships, further accelerating technology adoption.
Key Highlights:
How is technological advancement influencing regional demand for Scissors Type Ultrasonic Scalpels?
Technological innovation is reshaping demand across all regions, with particular impact on the integration of scissors‑type ultrasonic scalpels into robot‑assisted surgical platforms. In North America, the convergence of ultrasonic energy with da Vinci and Mako robotic systems enables surgeons to achieve sub‑millimeter precision while maintaining consistent cutting forces, thereby expanding the clinical indications for the device beyond traditional neurosurgery into complex cardiac and thoracic procedures. In Asia‑Pacific, emerging AI‑driven tissue‑recognition algorithms are being embedded into ultrasonic generators, allowing real‑time adjustments of vibration amplitude based on tissue density, which appeals to high‑volume centers seeking workflow efficiency. European hospitals are emphasizing sustainability, prompting manufacturers to develop energy‑efficient ultrasonic units that reduce overall power consumption without compromising performance. Across the Middle East, the adoption of tele‑medicine‑linked intra‑operative data platforms is driving demand for devices that can transmit cutting metrics to remote experts for real‑time consultation.
Key Highlights:
Several countries are establishing themselves as investment magnets for scissors‑type ultrasonic scalpel technologies. The United States remains a primary hub due to its extensive network of academic medical centers and venture‑capital–backed med‑tech startups focused on energy‑based devices. China, driven by the rapid expansion of tertiary hospitals and government‑sponsored “National Surgical Quality Improvement” programs, is attracting both domestic and foreign capital. India’s burgeoning private‑hospital sector, bolstered by rising per‑capita health spending, is seeing increased foreign direct investment from OEMs seeking to localize production. In Europe, Germany’s strong engineering base and Italy’s specialty surgical instrument clusters provide attractive environments for joint‑venture manufacturing. The United Arab Emirates and Saudi Arabia are also emerging as strategic hubs, leveraging sovereign wealth funds to fund hospital‑building projects that prioritize state‑of‑the‑art surgical suites equipped with ultrasonic technology.
Modernization of healthcare facilities is a decisive catalyst for regional growth in the scissors‑type ultrasonic scalpel market. In North America, legacy operating rooms are being retrofitted with modular energy‑based platforms to replace outdated electrosurgical units, a shift supported by hospital‑wide capital‑budget cycles that prioritize technology that improves patient safety and turnover rates. Europe’s “Digital Hospital” initiatives are prompting upgrades to operating theatres equipped with integrated imaging and ultrasonic cutting devices, thereby creating a seamless workflow for multi‑disciplinary teams. The Asia‑Pacific region is witnessing large‑scale construction of new specialty hospitals that are commissioned with the latest ultrasonic technology as a standard, reflecting policies that encourage minimally invasive surgery to reduce post‑operative length of stay. In South America, Brazil’s public‑health reform aims to upgrade over 1,200 operating rooms by 2028, with a significant portion earmarked for advanced energy‑based instruments. Middle Eastern national health strategies are accelerating the rollout of smart operating theatres that incorporate data‑rich ultrasonic scalpel systems for performance monitoring and continuous quality improvement.
Key Highlights:
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include Johnson & Johnson, Surgnova, Hemony Pharmaceutical, ShanghaiSAINTS SAGESSurgical, Innolcon Medical Technology, Beijing Taktvoll Technology, Stryker, among others.
-> Key growth drivers include rising demand for minimally invasive surgeries, increasing prevalence of chronic diseases, advancements in ultrasonic technology that improve precision and reduce intra‑operative bleeding, and expanding geriatric population worldwide.
-> North America holds the largest market share due to early adoption of advanced surgical devices, while Asia‑Pacific is the fastest‑growing region driven by rapid hospital infrastructure expansion in China, Japan, and South Korea.
-> Emerging trends include integration of ultrasonic scalpels with robotic surgery platforms, development of disposable, single‑use heads to enhance sterility, AI‑assisted energy modulation for tissue‑specific cutting, and sustainability initiatives focusing on recyclable instrument components.
